The Academic Programs Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the academic legal community. The Committee discusses various programs, publications, pricing, dissemination vehicles, etc. that best facilitate expanding FDLI’s educational mission.

Judith Meritz, Baker, Donelson, Bearman, Caldwell & Berkowitz, PC
Chair

Ralph Hall, University of Minnesota
Vice Chair

Barry Berger, GlaxoSmithKline

Annemarie Boyan, Drexel University

James Czaban, Wiley Rein LLP

Lewis Grossman, Covington & Burling LLP

William Janssen, Charleston Law School

Philip Katz, Hogan & Hartson, LLP

Eleanor Kinney, Indiana University School of Law - Indianapolis

William Kitchens, Arnall Golden Gregory LLP

Francis Palumbo, University of Maryland School of Pharmacy

Peter Safir, Covington & Burling LLP

Sheila Shulman, State University of NY at Buffalo

Victoria Sutton, Texas Tech University

Roseann Termini, Widener University School of Law

Geoffrey Levitt, Wyeth Pharmaceuticals
Chair

James Czaban, Wiley Rein LLP

Coleen Klasmeier, Sidley Austin LLP

Stuart Land, Arnold & Porter LLP

The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.

James Czaban, Wiley Rein LLP
Chair

Bruce Patsner, University of Houston
Vice Chair

Thomas Colonna

Lewis Grossman, Covington & Burling LLP

David Gryte, Astrazeneca Pharmaceuticals

Christina Markus, King & Spalding, LLP

Christine Mulshine, Children's Medical Center-Ambulatory Care Pavilion

Deborah Shelton, Sheppard, Mulllin, Richter & Hampton, LLP

The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.

Philip Katz, Hogan & Hartson, LLP
Chair

Michael Bernstein, FDA - CDER

Paul Ferrari, Hyman, Phelps & McNamara, P.C.

Michael Gaba, Holland & Knight, LLP

Matthew Kyle, Millennium Medical Technologies, Inc.

Peter Mathers, Kleinfeld, Kaplan & Becker

Roseann Termini, Widener University School of Law

Matthew Van Hook, U.S. Pharmacopeia

Kirke Weaver, Merck & Co., Inc.

William Schultz, Zuckerman, Spaeder
Chair

Nancy Buc, Buc & Beardsley
Immediate Past Chair

Frederick Degnan, King & Spalding, LLP
Vice Chair

James Kelly, FDLI
President & CEO

Jeffrey Gibbs, Hyman, Phelps & McNamara, P.C.
Secretary and General Counsel

Linda Suydam, Consumer Healthcare Products Association
Treasurer

Minnie Baylor-Henry, Deloitte & Touche LLP

Robert Brackett, Grocery Manufacturers Association

Mark DuVal, DuVal & Associates, P.A.

Mark Frankel, AAAS

Christopher Hagenbush, Patton Boggs LLP

Ralph Hall, University of Minnesota

Geoffrey Levitt, Wyeth Pharmaceuticals

Erika Lietzan, Covington & Burling LLP

Patricia Shrader, BD

John Taylor, Biotechnology Industry Organization

The Drugs and Biologics Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the drugs and biologics industries. The Committee advises staff on the appropriateness of conferences and publications relating to pharmaceuticals and biologics by reviewing and commenting on proposals.

Donald Beers, FDA - OC
Chair

Lesley Frank, FDA - CDER
Guest

Jennifer Ross, FDA - CBER
Guest

Bruce Artim, Eli Lilly and Company

Deborah Autor, FDA - CDER

Edward Berg, Sanofi-Aventis

Shawn Brown, Generic Pharmaceutical Association

Howard Dorfman, Ropes & Gray, LLP

Andrew Fish, Consumer Healthcare Products Association

Philip Katz, Hogan & Hartson, LLP

Patricia Knight, FoxKiser

Daniel Kracov, Arnold & Porter LLP

Scott Lassman, Kleinfeld, Kaplan & Becker

John Manthei, Latham & Watkins

Daniel Meron, Latham & Watkins

Joseph Metro, Reed Smith LLP

Sandra Milligan, Amgen Inc.

Sara Radcliffe, Biotechnology Industry Organization

The Journal Editorial Advisory Board promotes the educational, scholarly, and other purposes of the Food and Drug Law Journal. Members of the Board serve as peer reviewers for papers submitted for publication and recommend topics for “special / symposia” issues.

Jeffrey Chasnow, Pfizer, Inc.
Chair

Anne Maher, Kleinfeld, Kaplan & Becker
Vice Chair

Tracy Berns, Covidien

Krista Carver, Covington & Burling LLP

Kirk Dobbins, King & Spalding, LLP

Melanie Fairchild-Dzanis, Nestle USA-Nutrition Division

Jeffrey Francer, PhRMA

Michael Gaba, Holland & Knight, LLP

Ralph Hall, University of Minnesota

Joel Hoffman, Sutherland Asbill & Brennan, LLP

Gregory Jaffe, Center for Science in the Public Interest

Gail Javitt, Johns Hopkins University

Gordon Jepson, Deeth Williams Wall LLP

Kyle Lathrop, W.L. Gore and Associates

Laurie Lenkel, FDA - OC

Natasha Leskovsek, Cooley Godward Kronish LLP

Mark Levy, Saul Ewing LLP

Deborah Livornese, Buc & Beardsley

Suzanne LoGalbo, Novartis Consumer Health, Inc.

Maura Martin, Sidley Austin LLP

Eric Olsen, Mars, Inc.

James O'Reilly, Baker & Daniels

Mark Schwartz, FDA - OC

Sheila Shulman, State University of NY at Buffalo

Bradley Thompson, Epstein Becker & Green, P.C.

David Weinstock, Boehringer Ingelheim Pharmaceuticals

Frances Wu, Personal Care Products Council

The Update Editorial Advisory Board promotes the highest levels of professional, educational, and scholarly written commentary on timely issues of interest to professionals in the areas of foods, drugs, biologics, medical devices, other healthcare technologies, and cosmetics in FDLI’s magazine The Board serves as a resource for FDLI staff to develop feature theme ideas, acquire articles of interest to readers, and advise on the magazine’s quality and success in serving the interests and needs of its readers.

Robert Nicholas, McDermott, Will & Emery
Chair

Barbara Binzak, Buchanan Ingersoll & Rooney PC
Vice Chair

Frederick Ball, Duane Morris LLP

Christopher Brown, Genentech, Inc.

Daniel Carmichael, Baker & Daniels

Megan Clark, FDA - OC

Elizabeth Fawell, Hogan & Hartson, LLP

Carrie Horn, Kleinfeld, Kaplan & Becker

William McGrath, Wiley Rein LLP

Stephanie Philbin, Goodwin Procter LLP

Rene Quashie, Drinker Biddle & Reath LLP

Larry Rosania, The Weinberg Group Inc.

Jeffrey Senger, FDA - OC

Sarah Vasani, King & Spalding, LLP

William Schultz, Zuckerman, Spaeder
Chair

Nancy L. Buc, Buc & Beardsley
Immediate Past Chair

Frederick Degnan, King & Spalding, LLP
Vice Chair

Jeffrey Gibbs, Hyman, Phelps & McNamara, P.C.
Secretary and General Counsel

Linda A. Suydam, DPA, Consumer Healthcare Products Association
Treasurer

The purpose of the Finance Committee is to ensure the responsible financial operations of FDLI. The Committee provides on-going oversight of the financial operations and investment policies of FDLI to ensure sound financial management. The Committee also advises the Board on the direction and control of financial matters. The Committee also ensures that the Board is well informed about the Institute's finances.

Linda Suydam, Consumer Healthcare Products Association
Chair

Maxine Fritz, Quintiles Consulting

Rady Johnson, Pfizer, Inc.

Brenton Saunders, Schering-Plough Corporation

The Food and Dietary Supplements Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the food and dietary supplement industries. The Committee advises staff on the appropriateness of conferences and publications relating to foods and dietary supplements by reviewing and commenting on proposals.

Martin Hahn, Hogan & Hartson, LLP
Chair

Susan Bernard, FDA - CFSAN
Guest

Robert Post, Department of Agriculture
Guest

R. Sowards, Texas Department of Health
Guest

Steven Armstrong, Campbell Soup Company

Nicole Coutrelis, Coutrelis & Associes

Todd Halpern, Wyeth Pharmaceuticals

Leslie Krasny, Keller and Heckman LLP

Rachel Lattimore, Arent Fox

Anne Maher, Kleinfeld, Kaplan & Becker

Steven Mister, Council for Responsible Nutrition

John Packman, The Coca-Cola Company

Steven Shapiro, Ullman, Shapiro & Ullman, LLP

Daniel Shaw, H.J. Heinz Company

Edward Steele, EAS Consulting Group, LLC

The Medical Devices Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the Medical Devices industries. The Committee advises staff on the appropriateness of conferences and publications relating to medical devices by reviewing and commenting on proposals.

Beverly Chernaik, FDA - OC
Chair

Philip Phillips, Becker & Associates Consulting, Inc.
Chair

Susan Alpert, Medtronic, Inc.

M. Elizabeth Bierman, Morgan, Lewis & Bockius, LLP

Mark Heller, Goodwin Procter LLP

Sheila Hemeon-Heyer, Boston Scientific Corporation Inc.

Charma Konnor, Phoenix Regulatory Associates, Ltd.

Mark Leahey, Medical Device Manufacturers Association

Joanne Less, FDA - OC

Carol Ley, 3M Company

Susan Moritz, BD

Steven Niedelman, Crowell & Moring LLP

Neil O'Flaherty, Olsson Frank Weeda Terman Bode Matz PC

Bradley Thompson, Epstein Becker & Green, P.C.

Casper Uldriks, FDA - CDRH

Mark DuVal, DuVal & Associates, P.A.
Chair

Frederick Branding, McGuireWoods LLP

Marsha Cohen, Hastings College of the Law

Bruce Deal, Analysis Group, Inc.

R. Bruce Dickson, Manatt, Phelps & Phillips, LLP

Janice Hogan, Hogan & Hartson, L.L.P.

Paul Hyman, Hyman, Phelps & McNamara, P.C.

Leslie Krasny, Keller and Heckman LLP

Laurie Lenkel, FDA - OC

David Scharf, Baxter International Inc.

Daniel Shaw, H.J. Heinz Company